Neuroimmunomodulation in Depression: A Review of Inflammatory Cytokines Involved in this Process

[1]  M. Maes,et al.  Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression , 2013, Pharmacological reports : PR.

[2]  H. Hartung,et al.  Citalopram suppresses thymocyte cytokine production , 2013, Journal of Neuroimmunology.

[3]  Amisha G Patel.  Review: the role of inflammation in depression. , 2013, Psychiatria Danubina.

[4]  F. Lotrich,et al.  Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications , 2013, Neuroscience.

[5]  A. Karson,et al.  Effects of long-term etanercept treatment on anxiety- and depression-like neurobehaviors in rats , 2013, Physiology & Behavior.

[6]  H. Abelaira,et al.  Imipramine reverses alterations in cytokines and BDNF levels induced by maternal deprivation in adult rats , 2013, Behavioural Brain Research.

[7]  K. Hashimoto,et al.  Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration , 2013, Pharmacology Biochemistry and Behavior.

[8]  J. Suvisaari,et al.  Inflammation theories in psychotic disorders: a critical review. , 2013, Infectious disorders drug targets.

[9]  P. Moynagh,et al.  The Pro-inflammatory Cytokine TNF-α Regulates the Activity and Expression of the Serotonin Transporter (SERT) in Astrocytes , 2013, Neurochemical Research.

[10]  J. Hensler,et al.  Interleukin-1beta Causes Fluoxetine Resistance in an Animal Model of Epilepsy-Associated Depression , 2012, Neurotherapeutics.

[11]  M. Maes,et al.  Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression , 2012, Neuroscience & Biobehavioral Reviews.

[12]  T. Bártfai,et al.  IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures , 2011, Brain, Behavior, and Immunity.

[13]  J. Suvisaari,et al.  Inflammation in psychotic disorders: A population-based study , 2011, Psychiatry Research.

[14]  Lisa Goehler,et al.  In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[15]  J. Kowalski,et al.  Interleukin-1beta Promoter (−31T/C and −511C/T) Polymorphisms in Major Recurrent Depression , 2011, Journal of Molecular Neuroscience.

[16]  Sang-Il Lee.  "Asia Pacific Allergy": A new leap forward , 2011, Asia Pacific Allergy.

[17]  S. Sirisinha.  Insight into the mechanisms regulating immune homeostasis in health and disease. , 2011, Asian Pacific journal of allergy and immunology.

[18]  T. Kircher,et al.  Regulatory T cells increased while IL-1β decreased during antidepressant therapy. , 2010, Journal of psychiatric research.

[19]  R. Dantzer,et al.  Central Administration of Lipopolysaccharide Induces Depressive-like Behavior in Vivo and Activates Brain Indoleamine 2,3 Dioxygenase In Murine Organotypic Hippocampal Slice Cultures , 2010, Journal of Neuroinflammation.

[20]  Luís Eduardo Coelho Andrade,et al.  Sistema imunitário: Parte I. Fundamentos da imunidade inata com ênfase nos mecanismos moleculares e celulares da resposta inflamatória , 2010 .

[21]  L. Rink,et al.  Regulatory T cells increased while IL-1beta decreased during antidepressant therapy , 2010 .

[22]  Volker Arolt,et al.  The Interleukin 1 Beta (IL1B) Gene Is Associated with Failure to Achieve Remission and Impaired Emotion Processing in Major Depression , 2010, Biological Psychiatry.

[23]  N. Herrmann,et al.  A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.

[24]  F. Brennan,et al.  Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors. , 2010, Arthritis and rheumatism.

[25]  A. Scarpa,et al.  MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines , 2009, Nucleic acids research.

[26]  Martin Samuelsson,et al.  Interleukin-6 Is Elevated in the Cerebrospinal Fluid of Suicide Attempters and Related to Symptom Severity , 2009, Biological Psychiatry.

[27]  R. Yoshimura,et al.  Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[28]  H. Hartung,et al.  The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines. , 2009, The international journal of neuropsychopharmacology.

[29]  Jing Du,et al.  A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. , 2009, The international journal of neuropsychopharmacology.

[30]  I. Goshen,et al.  Interleukin-1 (IL-1): A central regulator of stress responses , 2009, Frontiers in Neuroendocrinology.

[31]  R. Dantzer,et al.  Central nervous action of interleukin‐1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide , 2008, European Journal of Neuroscience.

[32]  F. Holsboer,et al.  Depression, comorbidities and the TNF-α system , 2008, European Psychiatry.

[33]  I. Goshen,et al.  Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression , 2008, Molecular Psychiatry.

[34]  G. Zunta-Soares,et al.  Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double‐blind, randomized, placebo‐controlled study , 2008, Human psychopharmacology.

[35]  M. Molina-hernandez,et al.  Antidepressant-like actions of minocycline combined with several glutamate antagonists , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[36]  R. Dantzer,et al.  Tumor necrosis factor-α-induced sickness behavior is impaired by central administration of an inhibitor of c-jun N-terminal kinase , 2008, Psychopharmacology.

[37]  F. Holsboer,et al.  Neuronal actions of glucocorticoids: Focus on depression , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[38]  W. Drevets,et al.  Sustained Low-Grade Pro-inflammatory State in Unmedicated, Remitted Women with Major Depressive Disorder as Evidenced by Elevated Serum Levels of the Acute Phase Proteins C-reactive Protein and Serum Amyloid A , 2007, Biological Psychiatry.

[39]  P. Scully,et al.  Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. , 2007, Journal of psychiatric research.

[40]  A. Siracusano,et al.  Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy. , 2006, The Journal of clinical psychiatry.

[41]  A. Young,et al.  The dex/CRH test—Is it better than the DST? , 2006, Psychoneuroendocrinology.

[42]  R. Dantzer.  Cytokine, sickness behavior, and depression. , 2006, Neurologic clinics.

[43]  C. Bai,et al.  Cytokines and serotonin transporter in patients with major depression , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[44]  R. Duman,et al.  TNFα Signaling in Depression and Anxiety: Behavioral Consequences of Individual Receptor Targeting , 2006, Biological Psychiatry.

[45]  E. Göka,et al.  IL‐6 levels decrease with SSRI treatment in patients with major depression , 2005, Human psychopharmacology.

[46]  T. Niewold,et al.  Acute phase reaction and acute phase proteins. , 2005, Journal of Zhejiang University. Science. B.

[47]  T. Erlinger,et al.  Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. , 2004, Archives of internal medicine.

[48]  L. Ferrucci,et al.  Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study , 2003, Biological Psychiatry.

[49]  O. Çalıyurt,et al.  Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder , 2003, Psychopharmacology.

[50]  Viola Vaccarino,et al.  Association Between Depression and Elevated C-Reactive Protein , 2003, Psychosomatic medicine.

[51]  Michael J. Owens,et al.  Treatment of mood disorders , 2002, Nature Neuroscience.

[52]  Jerry W Rudy,et al.  Memory for context is impaired by a post context exposure injection of interleukin-1 beta into dorsal hippocampus , 2002, Behavioural Brain Research.

[53]  A. Nagai,et al.  Cytokines, chemokines, and cytokine receptors in human microglia , 2002, Journal of neuroscience research.

[54]  M. Bala,et al.  Infliximab Improves Quality of Life in Patients with Crohn's Disease , 2002, Inflammatory bowel diseases.

[55]  L. Fried,et al.  Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. , 2002, The American journal of cardiology.

[56]  I. Everall,et al.  Expression of β‐chemokines and chemokine receptors in human fetal astrocyte and microglial co‐cultures: Potential role of chemokines in the developing CNS , 2002, Glia.

[57]  B. Curran,et al.  The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro , 2001, Neuroscience.

[58]  A. Dunn,et al.  Behavioral Effects of Cytokines , 2001, Brain, Behavior, and Immunity.

[59]  E. Bosmans,et al.  Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis , 2001, European Neuropsychopharmacology.

[60]  T. Pollmächer,et al.  Cytokine-associated emotional and cognitive disturbances in humans. , 2001, Archives of general psychiatry.

[61]  T. J. Nickola,et al.  Antidepressant Drug-Induced Alterations in Neuron-Localized Tumor Necrosis Factor-α mRNA and α2-Adrenergic Receptor Sensitivity , 2001 .

[62]  R. Dantzer.  Cytokine‐Induced Sickness Behavior: Mechanisms and Implications , 2001, Annals of the New York Academy of Sciences.

[63]  M. Maes.  The immunoregulatory effects of antidepressants , 2001, Human psychopharmacology.

[64]  R. Yirmiya.  Depression in medical illness: the role of the immune system. , 2000, The Western journal of medicine.

[65]  R. Dantzer,et al.  Role of IL-6 in cytokine-induced sickness behavior a study with IL-6 deficient mice , 2000, Physiology & Behavior.

[66]  D. Remick,et al.  Cytokines and the brain: implications for clinical psychiatry. , 2000, The American journal of psychiatry.

[67]  H. Vedder,et al.  Cytokine Production and Treatment Response in Major Depressive Disorder , 2000, Neuropsychopharmacology.

[68]  J. W. Rudy,et al.  Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation , 1999, Behavioural Brain Research.

[69]  J. Levine,et al.  Cerebrospinal Cytokine Levels in Patients with Acute Depression , 1999, Neuropsychobiology.

[70]  R. Duman.  Novel therapeutic approaches beyond the serotonin receptor , 1998, Biological Psychiatry.

[71]  E. Bosmans,et al.  Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. , 1997, Cytokine.

[72]  J. Herman,et al.  Neurocircuitry of stress: central control of the hypothalamo–pituitary–adrenocortical axis , 1997, Trends in Neurosciences.

[73]  R. Spengler,et al.  Changes in noradrenergic sensitivity to tumor necrosis factor-α in brains of rats administered clonidine , 1996, Journal of Neuroimmunology.

[74]  J. Levine,et al.  Possible antidepressant effect of minocycline. , 1996, The American journal of psychiatry.

[75]  C. Janeway.  Immunobiology: The Immune System in Health and Disease , 1996 .

[76]  C. Newton,et al.  Spatial Learning Impairment in Mice Infected with Legionella pneumophila or Administered Exogenous Interleukin-1-β , 1995, Brain, Behavior, and Immunity.

[77]  Michael Maes,et al.  Evidence for an immune response in major depression: A review and hypothesis , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[78]  S. Manuck,et al.  Cardiovascular reactivity and the course of immune response to an acute psychological stressor. , 1994, Psychosomatic medicine.

[79]  G. Siggins,et al.  Interleukin 1β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus , 1993, Brain Research.

[80]  M. Oitzl,et al.  Interleukin-1β, but not interleukin-6, impairs spatial navigation learning , 1993, Brain Research.

[81]  R. Dantzer,et al.  Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[82]  R. Dantzer,et al.  Effects of lipopolysaccharide on food-motivated behavior in the rat are not blocked by an interleukin-1 receptor antagonist , 1992, Neuroscience Letters.

[83]  A. Denman.  Cellular and Molecular Immunology , 1992 .

[84]  R. S. Smith.  The macrophage theory of depression. , 1991, Medical hypotheses.

[85]  P. Matangkasombut.  Studies of lymphocyte subpopulations and their clinical implications. , 1983, Asian Pacific journal of allergy and immunology.

[86]  I. Kushner.  THE PHENOMENON OF THE ACUTE PHASE RESPONSE * , 1982, Annals of the New York Academy of Sciences.

[87]  A. Kraneveld,et al.  The neuro-immune axis: prospect for novel treatments for mental disorders. , 2014, Basic & clinical pharmacology & toxicology.

[88]  D. F. Drake,et al.  A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. , 2013, JAMA psychiatry.

[89]  D. Kurcgant,et al.  Cytokine profiles in women with different subtypes of major depressive disorder. , 2007, Journal of psychiatric research.

[90]  T. J. Nickola,et al.  Antidepressant drug-induced alterations in neuron-localized tumor necrosis factor-alpha mRNA and alpha(2)-adrenergic receptor sensitivity. , 2001, The Journal of pharmacology and experimental therapeutics.

[91]  C. Janeway,et al.  The Immune System in Health and Disease , 2001 .

[92]  M. Maes,et al.  Major depression and activation of the inflammatory response system. , 1999, Advances in experimental medicine and biology.

[93]  S. Maier,et al.  Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. , 1998, Psychological review.

[94]  P. Gillet,et al.  Effects of continuous infusion of interleukin 1 beta on corticotropin-releasing hormone (CRH), CRH receptors, proopiomelanocortin gene expression and secretion of corticotropin, beta-endorphin and corticosterone. , 1997, Neuroendocrinology.

[95]  M. Oitzl,et al.  Interleukin-1 beta, but not interleukin-6, impairs spatial navigation learning. , 1993, Brain Research.

[96]  R. Dantzer,et al.  Sickness behavior as a new target for drug development. , 1992, Trends in pharmacological sciences.